Open access
Aug 2026
T-cell engager bispecific antibodies enable T cells to eliminate Multiple Myeloma by targeting tumor CD38 in combination with PD-L1
In vitro data revealed that a bispecific antibody simultaneously engaging PD-L1 and CD38 exhibited markedly enhanced antitumor efficacy—even under conditions of reduced CD38 surface expression on MM cells.
Chaofan Wang, Wanting Wang, Mo-Ran Wang et al.
· Cell Death & Disease · 0 citations